Nepentes Pharma Overview

  • Founded
  • 1991
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 235
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Nepentes Pharma General Information

Description

A pharmaceutical Company is engaged in manufacturing Iwostin, Emolium, Elixine, Propodia, ApiPanten, Propolki and Propolets and selling these products in across Central and Eastern Europe.

Contact Information

Website
www.nepentes.pl
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors (Healthcare)
Other Industries
Pharmaceuticals
Parent Company
Sanofi Polska
Primary Office
  • UL. GWIAŹDZISTA 69F
  • WARSAW
  • WARSAW, 01-651
  • Poland
+48 0000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nepentes Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nepentes Pharma‘s full profile, request access.

Request a free trial

Nepentes Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nepentes Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nepentes Pharma‘s full profile, request access.

Request a free trial